Matrix metallopropteinases in heart failure.
Heart failure (HF) represents a complex multifactorial syndrome, characterized by crucial structural and functional abnormalities of the myocardium. Matrix metalloproteinases are associated with left ventricular dysfunction, adverse left ventricular remodelling and prognosis after acute myocardial i...
المؤلفون الرئيسيون: | Tousoulis, D, Kampoli, A, Papageorgiou, N, Antoniades, C, Siasos, G, Latsios, G, Tsiamis, E, Stefanadis, C |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2012
|
مواد مشابهة
-
Matrix metalloproteinases in acute coronary syndromes: current perspectives.
حسب: Kampoli, A, وآخرون
منشور في: (2012) -
Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
حسب: Briasoulis, A, وآخرون
منشور في: (2012) -
Circulating biomarkers for the diagnosis and prognosis of heart failure.
حسب: Tousoulis, D, وآخرون
منشور في: (2009) -
Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
حسب: Gounari, P, وآخرون
منشور في: (2010) -
C-reactive protein and endothelial dysfunction: gazing at the coronaries.
حسب: Tousoulis, D, وآخرون
منشور في: (2011)